Figure 5

Quantitative amount of (A) Aβ1–40 and (B) Aβ1–42 in 7PA2 cells after treating with CRT formulations. *p < 0.05 compared with control; **p < 0.01 compared with control.

Quantitative amount of (A) Aβ1–40 and (B) Aβ1–42 in 7PA2 cells after treating with CRT formulations. *p < 0.05 compared with control; **p < 0.01 compared with control.